2 results
Approved WMOCompleted
Primary Objectives:1. To evaluate the efficacy of anacetrapib 100 mg for 24 weeks relative to placeboon plasma concentrations of LDL-C (BQ method).2. To evaluate the efficacy of anacetrapib 100 mg for 24 weeks relative to placeboon plasma…
Approved WMOCompleted
Objective of the study is to demonstrate that CRT parameter optimisation using SonR technology can improve the responder rate, when using LV remodeling as a reference, compared to Standard of Care.